181 related articles for article (PubMed ID: 17288344)
21. Update on evaluating complement in hemolytic uremic syndrome.
Kavanagh D; Goodship TH
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
[TBL] [Abstract][Full Text] [Related]
22. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells.
Heinen S; Józsi M; Hartmann A; Noris M; Remuzzi G; Skerka C; Zipfel PF
J Am Soc Nephrol; 2007 Feb; 18(2):506-14. PubMed ID: 17229916
[TBL] [Abstract][Full Text] [Related]
23. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
[TBL] [Abstract][Full Text] [Related]
24. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
[TBL] [Abstract][Full Text] [Related]
25. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.
Caprioli J; Castelletti F; Bucchioni S; Bettinaglio P; Bresin E; Pianetti G; Gamba S; Brioschi S; Daina E; Remuzzi G; Noris M;
Hum Mol Genet; 2003 Dec; 12(24):3385-95. PubMed ID: 14583443
[TBL] [Abstract][Full Text] [Related]
26. Complement regulatory genes and hemolytic uremic syndromes.
Kavanagh D; Richards A; Atkinson J
Annu Rev Med; 2008; 59():293-309. PubMed ID: 17705684
[TBL] [Abstract][Full Text] [Related]
27. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.
Westra D; Wetzels JF; Volokhina EB; van den Heuvel LP; van de Kar NC
Neth J Med; 2012 Apr; 70(3):121-9. PubMed ID: 22516576
[TBL] [Abstract][Full Text] [Related]
28. Recurrence of hemolytic uremic syndrome after renal transplantation.
Seitz B; Albano L; Vocila F; Mzoughi S; Aoudia R; Guitard J; Ribes D; Vachet-Copponat H; Mourad G; Bienaimé F; Dahan P; Frémeaux-Bacchi V; Cassuto E
Transplant Proc; 2007 Oct; 39(8):2583-5. PubMed ID: 17954182
[TBL] [Abstract][Full Text] [Related]
29. The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome.
Szilágyi A; Kiss N; Bereczki C; Tálosi G; Rácz K; Túri S; Györke Z; Simon E; Horváth E; Kelen K; Reusz GS; Szabó AJ; Tulassay T; Prohászka Z
Nephrol Dial Transplant; 2013 Sep; 28(9):2237-45. PubMed ID: 23787556
[TBL] [Abstract][Full Text] [Related]
30. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
Dragon-Durey MA; Blanc C; Marliot F; Loirat C; Blouin J; Sautes-Fridman C; Fridman WH; Frémeaux-Bacchi V
J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718
[TBL] [Abstract][Full Text] [Related]
31. Does complement factor B have a role in the pathogenesis of atypical HUS?
Kavanagh D; Kemp EJ; Richards A; Burgess RM; Mayland E; Goodship JA; Goodship TH
Mol Immunol; 2006 Mar; 43(7):856-9. PubMed ID: 16061287
[TBL] [Abstract][Full Text] [Related]
32. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
[TBL] [Abstract][Full Text] [Related]
33. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
Saunders RE; Goodship TH; Zipfel PF; Perkins SJ
Hum Mutat; 2006 Jan; 27(1):21-30. PubMed ID: 16281287
[TBL] [Abstract][Full Text] [Related]
34. Transplantation in atypical hemolytic uremic syndrome.
Kavanagh D; Richards A; Goodship T; Jalanko H
Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
[TBL] [Abstract][Full Text] [Related]
35. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
[TBL] [Abstract][Full Text] [Related]
36. Where next with atypical hemolytic uremic syndrome?
Jokiranta TS; Zipfel PF; Fremeaux-Bacchi V; Taylor CM; Goodship TJ; Noris M
Mol Immunol; 2007 Sep; 44(16):3889-900. PubMed ID: 17768107
[TBL] [Abstract][Full Text] [Related]
37. Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?
Poolpol K; Gadner B; Neururer S; Mellmann A; Karch H; Orth D; Würzner R
Int J Immunogenet; 2011 Oct; 38(5):383-7. PubMed ID: 21649859
[TBL] [Abstract][Full Text] [Related]
38. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue.
Atkinson JP; Liszewski MK; Richards A; Kavanagh D; Moulton EA
Ann N Y Acad Sci; 2005 Nov; 1056():144-52. PubMed ID: 16387683
[TBL] [Abstract][Full Text] [Related]
39. [Hemolytic uremic syndrome].
Rota S; Cravedi P; Remuzzi G; Ruggenenti P
G Ital Nefrol; 2005; 22 Suppl 33():S57-64. PubMed ID: 16419008
[TBL] [Abstract][Full Text] [Related]
40. [The genetic background of haemolytic-uraemic syndrome].
Zurowska A
Przegl Lek; 2006; 63 Suppl 3():15-6. PubMed ID: 16898478
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
